107 related articles for article (PubMed ID: 38718624)
1. Anticancer activity of 8-hydroxyquinoline-triphenylphosphine rhodium(III) complexes targeting mitophagy pathways.
Huang XQ; Wu RC; Liang JM; Zhou Z; Qin QP; Liang H
Eur J Med Chem; 2024 Jun; 272():116478. PubMed ID: 38718624
[TBL] [Abstract][Full Text] [Related]
2. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
3. Comparative solution equilibrium studies of antitumor ruthenium(η
Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA
Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Camphor-Derived Bis(pyrazolylpyridine) Rhodium(III) Complexes: Structure-Reactivity Relationships and Biological Activity.
Petrović A; Milutinović MM; Petri ET; Živanović M; Milivojević N; Puchta R; Scheurer A; Korzekwa J; Klisurić OR; Bogojeski J
Inorg Chem; 2019 Jan; 58(1):307-319. PubMed ID: 30565467
[TBL] [Abstract][Full Text] [Related]
6. Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Wirth S; Rohbogner CJ; Cieslak M; Kazmierczak-Baranska J; Donevski S; Nawrot B; Lorenz IP
J Biol Inorg Chem; 2010 Mar; 15(3):429-40. PubMed ID: 20091072
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.
Richert M; Walczyk M; Cieślak MJ; Kaźmierczak-Barańska J; Królewska-Golińska K; Wrzeszcz G; Muzioł T; Biniak S
Dalton Trans; 2019 Jul; 48(28):10689-10702. PubMed ID: 31241117
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, DFT Calculations, Antiproliferative, Bactericidal Activity and Molecular Docking of Novel Mixed-Ligand Salen/8-Hydroxyquinoline Metal Complexes.
Al-Farhan BS; Basha MT; Abdel Rahman LH; El-Saghier AMM; Abou El-Ezz D; Marzouk AA; Shehata MR; Abdalla EM
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443314
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria-localizing triphenylphosphine-8-hydroxyquinoline Ru complexes induce ferroptosis and their antitumor evaluation.
Meng T; Xu Z; Wang HJ; Huang J; Wen JL; Huang MP; Zhou CY; Zhong JP
J Inorg Biochem; 2024 Aug; 257():112585. PubMed ID: 38718498
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Rhodium(III) complexes with 2(1H)-quinolinone derivatives and evaluation of their in vitro and in vivo antitumor activity.
Lu X; Wu YM; Yang JM; Ma FE; Li LP; Chen S; Zhang Y; Ni QL; Pan YM; Hong X; Peng Y
Eur J Med Chem; 2018 May; 151():226-236. PubMed ID: 29614419
[TBL] [Abstract][Full Text] [Related]
12. 8-Hydroxyquinoline derived p-halo N4-phenyl substituted thiosemicarbazones: Crystal structures, spectral characterization and in vitro cytotoxic studies of their Co(III), Ni(II) and Cu(II) complexes.
Kotian A; Kamat V; Naik K; Kokare DG; Kumara K; Neratur KL; Kumbar V; Bhat K; Revankar VK
Bioorg Chem; 2021 Jul; 112():104962. PubMed ID: 33992968
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
[TBL] [Abstract][Full Text] [Related]
14. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
15. Rhodium(III) Dihalido Complexes: The Effect of Ligand Substitution and Halido Coordination on Increasing Cancer Cell Potency.
Lord RM; Zegke M; Basri AM; Pask CM; McGowan PC
Inorg Chem; 2021 Feb; 60(3):2076-2086. PubMed ID: 33463147
[TBL] [Abstract][Full Text] [Related]
16. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines.
Weber B; Serafin A; Michie J; Van Rensburg C; Swarts JC; Bohm L
Anticancer Res; 2004; 24(2B):763-70. PubMed ID: 15161024
[TBL] [Abstract][Full Text] [Related]
18. 8-Hydroxyquinoline-Amino Acid Hybrids and Their Half-Sandwich Rh and Ru Complexes: Synthesis, Anticancer Activities, Solution Chemistry and Interaction with Biomolecules.
Pivarcsik T; Dömötör O; Mészáros JP; May NV; Spengler G; Csuvik O; Szatmári I; Enyedy ÉA
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681939
[TBL] [Abstract][Full Text] [Related]
19. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
[TBL] [Abstract][Full Text] [Related]
20. Search for new biologically active compounds:
Mitrović M; Djukić MB; Vukić M; Nikolić I; Radovanović MD; Luković J; Filipović IP; Matić S; Marković T; Klisurić OR; Popović S; Matović ZD; Ristić MS
Dalton Trans; 2024 Jun; 53(22):9330-9349. PubMed ID: 38747564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
